Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults.
Barring a shocking development where the Cubs acquire another starter in some aspect, the current state of the Cubs rotation is the same rotation they will be t ...